Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.


2023-08-17	1 : 50 2 %
2021-01-04	1 : 35 2.86 %
2018-01-23	1 : 5 20 %

Helius Medical Technologies, Inc.

HSDT | NASDAQ Capital Market

On 2023-08-17, Helius Medical Technologies, Inc. underwent a 1 : 50 stock split, leading to a 2% shift in the total share count.